Deborah Franke Speranzo Email & Phone Number

Within the therapeutic area haematology, immunology and specialty care, Sobi is dedicated to the treatment of rare, ultra-rare and severe diseases. This dedication combined with a rare expertise has resulted in a long history of developing transformative treatments for patients with high unmet medical needs. Our ability to identify unmet medical needs, develop treatments and secure evidence has been instrumental in the success of our current therapies. We keep challenging the status quo and are dedicated to the continuous discovery of high-potential therapies that we can develop to make a lasting impact and create sustainable value, sooner rather than later. Through close collaboration with rare disease communities, we continue to improve access to care for those otherwise overlooked.

San Rafael, Ca, Us

At BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. Transforming lives through genetic discovery.

Cambridge, Ma, Us

Where science meets heart. Passionately committed to transforming the lives of people with genetically defined rare diseases including Pyruvate Kinase Deficiency (PKD), Thalassemias and Sickle-Cell Disease.

Basel, Baselstadt, Ch

AveXis is now Novartis Gene Therapies. Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. (SMA, Spinal Muscle Atrophy, rare neurological disease, gene therapy, Zolgensma)

At AveXis, we work relentlessly to bring gene therapy to patients and families affected by rare and life-threatening neurological genetic diseases, like spinal muscular atrophy (SMA), Rett syndrome (RTT), and a genetic form of amyotrophic lateral sclerosis (ALS). Our dedication to advancing gene-based medicine can make a difference in the fight against devastating hereditary diseases.

Waltham, Ma, Us

Hemophilia, rare disease2014 President's Circle Winner2016 President's Circle WinnerBioverativ is dedicated to transforming the lives of people with hemophilia, cold agglutinin disease and other rare blood disorders. As an independent biopharmaceutical company spun out of Biogen’s hemophilia business, it brings a strong legacy of innovation, world-class science, and commitment to the rare blood disorders community. Bioverativ is united by a singular purpose: to create progress where patients need it most.

Cambridge, Ma, Us

Hemophilia, rare disease2014 President's Circle Winner2016 President's Circle WinnerBiogen is a pioneer in neuroscience. Since its founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological and hematologic diseases.

Phoenix, Az, Us

Avella is a national specialty pharmacy dedicated to empowering patients, providers and other organizations across the entire healthcare continuum. Invested in improving the health—and the lives—of the people they serve, Avella accomplishes this goal by acting as expert clinicians, passionate advocates, committed healthcare partners and strategic innovators.

Thousand Oaks, Ca, Us

Amgen was incorporated on April 8, 1980, in Thousand Oaks, California, during the dawn of biotechnology. The company was created around a simple idea—that emerging research in biology could lead to meaningful advances if the right scientists could be assembled and given the appropriate resources. Since then, Amgen has grown to be one of the world's leading biotechnology companies, deeply rooted in science and innovation and focused on helping patients with serious illness.

Thousand Oaks, Ca, Us

Strategic Training Manager - Inflammation Business Unit

Thousand Oaks, Ca, Us

Immunex was acquired by Amgen in 2002

Lawrence Township, Nj, Us

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Deborah's areas of focus at BMS was Cardiology, Endocrinology, Neurology, Internal Medicine & Primary Care Sales.